Artwork

Content provided by JNM. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by JNM or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Advances in Dementia Imaging: Insights from Experts

29:07
 
Share
 

Manage episode 428528540 series 3585940
Content provided by JNM. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by JNM or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

The Journal of Nuclear Medicine presents a new podcast on advances in dementia imaging. Panelists discuss the importance of amyloid and tau PET imaging in dementia diagnosis and treatment, highlighting their roles in clinical trials and future therapies. They emphasize the significance of early detection and the potential for personalized medicine approaches.
Panel:
• Ken Herrmann, MD, MBA (Universitätsmedizin, Essen, Germany)
• Henryk Barthel, MD, PhD (Leipzig University)
• Gil Rabinovici, MD (University of California - San Francisco)
• Victor Villemagne, MD (University of Pittsburgh)

  continue reading

4 episodes

Artwork
iconShare
 
Manage episode 428528540 series 3585940
Content provided by JNM. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by JNM or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

The Journal of Nuclear Medicine presents a new podcast on advances in dementia imaging. Panelists discuss the importance of amyloid and tau PET imaging in dementia diagnosis and treatment, highlighting their roles in clinical trials and future therapies. They emphasize the significance of early detection and the potential for personalized medicine approaches.
Panel:
• Ken Herrmann, MD, MBA (Universitätsmedizin, Essen, Germany)
• Henryk Barthel, MD, PhD (Leipzig University)
• Gil Rabinovici, MD (University of California - San Francisco)
• Victor Villemagne, MD (University of Pittsburgh)

  continue reading

4 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide